The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which ...

Cambridge headquartered global pharma company AstraZeneca is investing C$820 million (US$570m) in Canada, creating more than ...

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...

Bariatric surgery significantly reduced long-term risk for decompensation and adverse outcomes in patients with obesity and ...

UK reignites Oxford-Cambridge Arc plan, aiming to double economic output, boost R&D, and rival global innovation hubs.

Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilitiesMADRID and CAMBRIDGE, Mass., ...

The Company History page lists out the major events in chronological order for AstraZeneca Pharma India Ltd. Company History - AstraZeneca Pharma India Ltd.

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...